rosiglitazone has been researched along with hydroxyl radical in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, B; Li, Z; Ma, YX; Niu, B; Wang, HZ; Xie, J; Yang, B; Zhang, D | 1 |
| Gao, L; Hong, B; Jiang, W; Si, S; Wang, M; Yang, Y; Zhang, Z; Zhao, G; Zheng, Z | 1 |
2 other study(ies) available for rosiglitazone and hydroxyl radical
| Article | Year |
|---|---|
Rosiglitazone improves post-infarction left ventricular contractile function in rats.
Topics: Animals; Echocardiography; Female; Hydroxyl Radical; Myocardial Contraction; NF-kappa B; PPAR gamma; Rats; Rats, Wistar; Reactive Oxygen Species; Rosiglitazone; Superoxides; Thiazolidinediones; Ventricular Function, Left | 2005 |
Identification of novel human high-density lipoprotein receptor Up-regulators using a cell-based high-throughput screening assay.
Topics: Actinomycetaceae; Biological Assay; Carbocyanines; Carcinoma, Hepatocellular; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fermentation; Fluorescent Dyes; Gene Expression Regulation; Genes, Reporter; Humans; Hydroxyl Radical; Isoflavones; Lipoproteins, HDL; Liver Neoplasms; Luciferases; PPAR gamma; Receptors, Lipoprotein; Recombinant Fusion Proteins; Rosiglitazone; Scavenger Receptors, Class B; Thiazolidinediones; Transcription, Genetic; Up-Regulation | 2007 |